

Referências bibliográficas
1. Marik PE et al. Immunonutrition in high-risk surgical patients: a systematic review and analysis of the literature. JPEN. 2010;34:378-386.
2. Takeuchi H et al. Clinical significance of perioperative immunonutrition for patients with esophageal cancer. World J Surg. 2007;31:2160-2167.
3. Daly JM et al. Enteral nutrition with supplemental arginine, RNA, and omega-3 fatty acids in patients after operation: immunologic, metabolic and clinical outcome. Surgery. 1992;112:56-67.
4. Farreras N et al. Effect of early postoperative enteral immunonutrition on wound healing in patients undergoing surgery for gastric cancer. Clin Nutr. 2005;24:55-65.
5. Waitzberg DL et al. Postsurgical infections are reduced with specialized nutrition support. World J Surg. 2006;30:1592-1604.
6. Atkinson S et al. A prospective, randomized, double-blind, controlled clinical trial of enteral immunonutrition in the critically ill. Guy’s Hospital Intensive Care Group. Crit Care Med. 1998;26:1164- 1172.
7. Bower RH et al. Early enteral administration of a formula (Impact) supplemented with arginine, nucleotides, and fish oil in intensive care unit patients: results of a multicenter, prospective, randomized, clinial trial. Crit Care Med. 1995;23:436-449.
8. Drover JW et al. Perioperative use of arginine-supplemented diets: a systematic review of the evidence. J Am Coll Surg. 2011;212:385-399.
A nova dieta da linha IMPACT® 1.5 pode auxiliar na redução do risco de infecções pós-operatórias e no tempo de internação de seu paciente.
Faça o Login ou Cadastre-se para ver todos os conteúdos exclusivos